Abstract
Biomarkers of Response to Romiplostim in Patients with Lower-Risk Myelodysplastic Syndrome (MDS) and Thrombocytopenia - Results of the Europe Trial By the Emsco Network
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have